despite Extraordinary Challenges in Early September
Prof. Richard L. SCHILSKY and Prof. Tae Won KIM chairing the ASCO/KSMO Joint Symposium on September 3, 2020 at KSMO Virtual 2020
In the face of the extraordinarily challenging of the Covid-19 global pandemic, the ASCO and Korean Society of Medical Oncology (KSMO) hosted the virtual joint symposium and ASCO Breakthrough session from September 3rd to 4th through KSMO 2020 Virtual webcast to 1,700 participants worldwide with real-time interactive Q&A.
ASCO/KSMO Joint Symposium: Accelerating Precision Medicine in Real-World
and Utilize Real-World Evidence First held in 2018, the ASCO/KSMO joint symposium has been held annually at the KSMO Annual Meeting. This year, the symposium covered: ● The TAPUR study: Learning from precision medicine in practice - Richard L. SCHILSKY (ASCO)
● CancerLINQ, ASCO's real-world data platform: Challenges and perspectives - Cory D. WIEGERT (CancerLinQ, ASCO)
● Research applications of CancerLINQ - Robert S. MILLER (CancerLinQ, ASCO)
● Initiation of KOSMOS (Korean Precision Medicine Project) - Jee Hyun KIM (Seoul National University Bundang Hospital, KSMO)
● Exploration of real-world Korean oncology data - Dae Young ZANG (Hallym University Medical Center, KSMO)
● The symposium was chaired by Prof. Richard L. SCHILSKY (Chief Medical Officer and Executive Vice President, ASCO) and Prof. Tae Won KIM (Chairman, Board of Directors, KSMO)
and Utilize Real-World Evidence First held in 2018, the ASCO/KSMO joint symposium has been held annually at the KSMO Annual Meeting. This year, the symposium covered: ● The TAPUR study: Learning from precision medicine in practice - Richard L. SCHILSKY (ASCO)
● CancerLINQ, ASCO's real-world data platform: Challenges and perspectives - Cory D. WIEGERT (CancerLinQ, ASCO)
● Research applications of CancerLINQ - Robert S. MILLER (CancerLinQ, ASCO)
● Initiation of KOSMOS (Korean Precision Medicine Project) - Jee Hyun KIM (Seoul National University Bundang Hospital, KSMO)
● Exploration of real-world Korean oncology data - Dae Young ZANG (Hallym University Medical Center, KSMO)
● The symposium was chaired by Prof. Richard L. SCHILSKY (Chief Medical Officer and Executive Vice President, ASCO) and Prof. Tae Won KIM (Chairman, Board of Directors, KSMO)
ASCO Breakthrough session webcast on September 4th, 2020
ASCO Breakthrough Session: Bench to Bedside Research in Oncology
ASCO and KSMO signed ASCO Breakthrough co-host agreement in 2018, and the highlights of the 2019 ASCO Breakthrough included:
● Learning about carcinogenesis and drug sensitivity from organoids - Shiladitya SENGUPTA (Harvard Medical School, USA)
● Application of organoids for understanding mutational signatures of ionizing radiation - Young Seok JU (KAIST, Korea)
● Microbiota, immune-tonus, and cancer: Biology - Thomas F. GAJEWSKI (The University of Chicago, USA)
● Microbiota, immune-tonus, and cancer: Clinical applications - Siew C NG (The Chinese University of Hong Kong, Hong Kong)
● The session was chaired by ASCO President Prof. Howard A. BURRIS (Sarah Cannon Research Institute, USA) and KSMO former Chairman Prof. Tae-You KIM (Seoul National University Hospital, Korea) Photos of the ASCO/KSMO Joint Symposium and ASCO Breakthrough session are available now.
● Application of organoids for understanding mutational signatures of ionizing radiation - Young Seok JU (KAIST, Korea)
● Microbiota, immune-tonus, and cancer: Biology - Thomas F. GAJEWSKI (The University of Chicago, USA)
● Microbiota, immune-tonus, and cancer: Clinical applications - Siew C NG (The Chinese University of Hong Kong, Hong Kong)
● The session was chaired by ASCO President Prof. Howard A. BURRIS (Sarah Cannon Research Institute, USA) and KSMO former Chairman Prof. Tae-You KIM (Seoul National University Hospital, Korea) Photos of the ASCO/KSMO Joint Symposium and ASCO Breakthrough session are available now.
Prof. Seock-Ah Im (KSMO 2020 Organizing Committee Chair) presenting opening remarks at KSMO Virtual 2020
The Korean Society of Medical Oncology (KSMO) has been actively cultivating expertise in medical oncology since the foundation of the society in 2005 and is being developed as the largest nation-wide cancer organization comprised of physicians and health-care professionals committed to the multidisciplinary approach for optimal cancer care in Korea.
KSMO 2021 will return on September 2-3, 2021 in Seoul, Korea. Mark your calendars today!
KSMO 2021 will return on September 2-3, 2021 in Seoul, Korea. Mark your calendars today!
